Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Cross-referencing NIH grants against published research and clinical trials to identify funding-evidence gaps for Hereditary Hemochromatosis. Strongest funded area: Basic Science. Largest gap: Epidemiology / Natural History.
Epidemiology / Natural HistoryPublished, Not NIH-Funded
55 publications in Case Report / Case Series but no NIH-funded grants found in Epidemiology / Natural History for hereditary hemochromatosis. Existing research activity suggests this may be a viable area for grant applications.
Epidemiology / Natural HistoryPublished, Not NIH-Funded
43 publications in Epidemiology / Natural History but no NIH-funded grants found in Epidemiology / Natural History for hereditary hemochromatosis. Existing research activity suggests this may be a viable area for grant applications.
Translational / Drug DevelopmentPublished, Not NIH-Funded
7 publications in Gene Therapy / Novel Therapeutics but no NIH-funded grants found in Translational / Drug Development for hereditary hemochromatosis. Existing research activity suggests this may be a viable area for grant applications.
Adjacent Research(5 grants)
These grants mention Hereditary Hemochromatosis as part of broader research but are not primarily focused on this disease. They are not included in the funding totals above.
Other(5)
OtherR01Active
Long-Acting, Short-Residing Nanochelators for Iron Overload Therapy
Choi, Hak Soo et al.·MASSACHUSETTS GENERAL HOSPITAL·BOSTON, MA
